X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Edelweiss Financial with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EDELWEISS FINANCIAL vs INDOCO REMEDIES - Comparison Results

EDELWEISS FINANCIAL    Change

Edelweiss is among the larger institutional brokerage firms in India, with a strong domestic investment-banking business. It has a good market share in the institutional broking, and strong presence in derivatives. While its strengths remain in priva... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    EDELWEISS FINANCIAL INDOCO REMEDIES EDELWEISS FINANCIAL/
INDOCO REMEDIES
 
P/E (TTM) x 13.1 63.8 20.5% View Chart
P/BV x 2.0 2.3 87.8% View Chart
Dividend Yield % 0.8 1.0 80.6%  

Financials

 EDELWEISS FINANCIAL   INDOCO REMEDIES
EQUITY SHARE DATA
    EDELWEISS FINANCIAL
Mar-18
INDOCO REMEDIES
Mar-17
EDELWEISS FINANCIAL/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs309360 85.8%   
Low Rs157249 62.9%   
Sales per share (Unadj.) Rs93.7119.0 78.8%  
Earnings per share (Unadj.) Rs9.78.4 116.3%  
Cash flow per share (Unadj.) Rs10.915.2 71.8%  
Dividends per share (Unadj.) Rs1.351.60 84.4%  
Dividend yield (eoy) %0.60.5 110.3%  
Book value per share (Unadj.) Rs72.970.7 103.1%  
Shares outstanding (eoy) m915.5092.15 993.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.52.6 97.1%   
Avg P/E ratio x24.036.4 65.8%  
P/CF ratio (eoy) x21.320.0 106.5%  
Price / Book Value ratio x3.24.3 74.2%  
Dividend payout %13.919.1 72.6%   
Avg Mkt Cap Rs m213,40328,083 759.9%   
No. of employees `00010.16.0 166.5%   
Total wages/salary Rs m13,5492,167 625.3%   
Avg. sales/employee Rs Th8,536.61,817.0 469.8%   
Avg. wages/employee Rs Th1,347.9359.0 375.5%   
Avg. net profit/employee Rs Th885.5127.7 693.5%   
INCOME DATA
Net Sales Rs m85,81010,968 782.4%  
Other income Rs m37640 947.6%   
Total revenues Rs m86,18611,007 783.0%   
Gross profit Rs m50,2181,565 3,209.7%  
Depreciation Rs m1,117633 176.5%   
Interest Rs m35,29562 56,836.1%   
Profit before tax Rs m14,182909 1,559.5%   
Minority Interest Rs m2780-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,599139 4,036.4%   
Profit after tax Rs m8,901771 1,155.0%  
Gross profit margin %58.514.3 410.2%  
Effective tax rate %39.515.3 258.8%   
Net profit margin %10.47.0 147.6%  
BALANCE SHEET DATA
Current assets Rs m385,9995,725 6,742.6%   
Current liabilities Rs m260,4895,454 4,776.0%   
Net working cap to sales %146.32.5 5,926.1%  
Current ratio x1.51.0 141.2%  
Inventory Days Days68962 1,107.0%  
Debtors Days Days11272 155.6%  
Net fixed assets Rs m7,5385,307 142.0%   
Share capital Rs m916184 496.7%   
"Free" reserves Rs m65,7916,331 1,039.2%   
Net worth Rs m66,7066,516 1,023.8%   
Long term debt Rs m273,0611,323 20,637.9%   
Total assets Rs m635,13511,970 5,306.2%  
Interest coverage x1.415.6 9.0%   
Debt to equity ratio x4.10.2 2,015.8%  
Sales to assets ratio x0.10.9 14.7%   
Return on assets %7.07.0 100.0%  
Return on equity %13.311.8 112.8%  
Return on capital %14.712.4 118.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1904,507 4.2%   
Fx outflow Rs m571,141 5.0%   
Net fx Rs m1333,366 4.0%   
CASH FLOW
From Operations Rs m-111,375886 -12,564.9%  
From Investments Rs m-23,283-1,706 1,365.2%  
From Financial Activity Rs m148,3461,316 11,275.1%  
Net Cashflow Rs m13,508497 2,720.2%  

Share Holding

Indian Promoters % 37.3 59.2 63.0%  
Foreign collaborators % 0.1 0.0 -  
Indian inst/Mut Fund % 0.0 12.5 -  
FIIs % 21.1 6.0 351.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.5 22.4 185.3%  
Shareholders   134,647 12,805 1,051.5%  
Pledged promoter(s) holding % 52.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare EDELWEISS FINANCIAL With:   TIL LTD  THOMAS COOK INDIA  COX & KINGS  TVS SRICHAKRA  ADANI PORTS & SEZ  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 139.4% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, INDOCO REMEDIES has posted a net profit of Rs 78 m (down 139.4% YoY). Sales on the other hand came in at Rs 2 bn (down 17.3% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

EDELWEISS FINANCIAL Announces Quarterly Results (2QFY19); Net Profit Up 27.5% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, EDELWEISS FINANCIAL has posted a net profit of Rs 3 bn (up 27.5% YoY). Sales on the other hand came in at Rs 27 bn (up 31.5% YoY). Read on for a complete analysis of EDELWEISS FINANCIAL's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

EDELWEISS FINANCIAL SHARE PRICE


Nov 16, 2018 (Close)

TRACK EDELWEISS FINANCIAL

  • Track your investment in EDELWEISS FINANCIAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON EDELWEISS FINANCIAL

EDELWEISS FINANCIAL - FINOLEX IND. COMPARISON

COMPARE EDELWEISS FINANCIAL WITH

MARKET STATS